US approves skin patch to treat depression

Federal regulators approved the first anti-depressant skin patch today, providing a different way to administer a drug already used by Parkinson’s disease patients.

The Food and Drug Administration approved the selegiline transdermal patch, agency spokeswoman Susan Cruzan said. The drug belongs to a class of medicines that is rarely a first or even second choice to treat depression.